Remarkably little is known about these enzymes in cancer although upregulation of KMO has been described in hepatocellular carcinoma.46 This may be due at least in part to the lack of availability of good antibodies, at least until recently, which is why we generated our own QPRT antibody. Here, KMO is linked to hepatocellular carcinoma.